Actively Recruiting
Biomarkers in Prediction of AMI
Led by University of Tartu · Updated on 2024-12-03
250
Participants Needed
2
Research Sites
59 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.
CONDITIONS
Official Title
Biomarkers in Prediction of AMI
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Initial decision in favour of further diagnostics of mesenteric ischaemia
You will not qualify if you...
- Age under 18 years
- Consent declined by patient or next of kin (delayed consent)
- Chronic mesenteric ischaemia without an acute event
- Immediate decision for withdrawal of further diagnostics and active treatment
- Referral from another hospital with already established diagnosis of AMI
- AMI diagnosed at surgery without previously having been considered
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Tartu University Hospital
Tartu, Estonia, 50406
Actively Recruiting
2
Lucerne Cantonal Hospital
Lucerne, Switzerland, 6000
Actively Recruiting
Research Team
A
Annika Reintam Blaser, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here